Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03455751 · ClinicalTrials.gov registry record · NA
Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03455751 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 10 participants.
The verdict
NCT03455751, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The primary objectives of this study are to evaluate the potential for preoperative pharmacogenomics (PGx) testing to positively influence postoperative opioid use through visual analog scale (VAS) guided administration of narcotic equivalent and lower pain scores as measured by OBAS in patients undergoing major abdominal surgery.
Interventions
- GENETIC PGx-guided post-operative pain management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-04-17 |
| Est. Completion | 2019-01-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03455751
The ClinicalTrials.gov registry entry for NCT03455751 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PGx-guided post-operative pain management is the first listed.
NCT03455751 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03455751 about?
NCT03455751 is a clinical study titled "Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery". The primary objectives of this study are to evaluate the potential for preoperative pharmacogenomics (PGx) testing to positively influence postoperative opioid use through visual analog scale (VAS) guided administration of narcotic equivalent and lower pain scores as measured by OBAS in patients und...
What is the current status of trial NCT03455751?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2018-04-17. Estimated completion is 2019-01-09.
What interventions are being tested in trial NCT03455751?
The interventions under investigation include: PGx-guided post-operative pain management (GENETIC).
Who is sponsoring clinical trial NCT03455751?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.